Immunotherapy Plus TKI Regimens Appear Promising for Patients With Renal Cell Carcinoma
In an interview with Targeted Oncology, Chung-Han (Joe) Lee, MD, PhD, discussed the use of different targeted therapy and immunotherapy strategies for the treatment of patients with metastatic kidney cancer.